Mevion Medical Systems develops radiation therapies for the treatment of cancer.
Mevion Medical Systems, Inc. (formerly Still River Systems, Inc.) is a radiation therapy company dedicated to advancing the treatment of cancer. As the pioneering developer of modern proton therapy systems, Mevion provides innovative, safe, and effective solutions by transforming advances in medical technology and science into practical clinical reality.Mevion’s flagship product, the MEVION S250 Proton Therapy System, is designed to preserve all of the treatment benefits of traditional proton therapy systems while removing the obstacles of size, cost, and complexity. Realizing this vision, Mevion has forever changed the economics and accessibility of proton therapy worldwide.Founded in 2004, Mevion is a privately held company headquartered in the Boston metropolitan area with international offices in the United Kingdom and Japan.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jun 14, 2018 | Private Equity(PE) | $150M | 2 | — | — | Detail |
Aug 4, 2014 | Private Equity(PE) | $200M | 2 | — | — | Detail |
Jun 25, 2013 | Private Equity(PE) | $55M | 1 | — | — | Detail |
Jan 1, 2009 | Series Unknown | $33M | 1 | — | — | Detail |
Oct 8, 2007 | Series C | $6.90M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Henan Maisheng Medical Technology | — | Private Equity(PE) |
HOPU Investment Management Company | — | Private Equity(PE) |
Caxton Advantage Life Sciences Fund | — | Private Equity(PE) |